ID: ALA4580347

Max Phase: Preclinical

Molecular Formula: C25H34N2O5

Molecular Weight: 442.56

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C1CC[C@H]2[C@@](C)(CCC(=O)N[C@@]2(C)COC(=O)[C@@H]2CCCN2)[C@@H]1/C=C/C1=CCOC1=O

Standard InChI:  InChI=1S/C25H34N2O5/c1-16-6-9-20-24(2,18(16)8-7-17-11-14-31-22(17)29)12-10-21(28)27-25(20,3)15-32-23(30)19-5-4-13-26-19/h7-8,11,18-20,26H,1,4-6,9-10,12-15H2,2-3H3,(H,27,28)/b8-7+/t18-,19+,20+,24+,25+/m1/s1

Standard InChI Key:  OLOTZDSWDWVPQN-ITAJTMSTSA-N

Associated Targets(Human)

Hexokinase type II 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 28094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 442.56Molecular Weight (Monoisotopic): 442.2468AlogP: 2.58#Rotatable Bonds: 5
Polar Surface Area: 93.73Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.89CX Basic pKa: 7.45CX LogP: 2.24CX LogD: 1.91
Aromatic Rings: 0Heavy Atoms: 32QED Weighted: 0.50Np Likeness Score: 2.31

References

1. Wang W, Wu Y, Yang K, Wu C, Tang R, Li H, Chen L..  (2019)  Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities.,  173  [PMID:31009914] [10.1016/j.ejmech.2019.04.022]

Source